We are live on ! Find out more
APP

Avantax Planning Partners Portfolio holdings

AUM $4.02B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+20%
3 Year Est. Return
+51.05%
5 Year Est. Return
+51.22%
10 Year Est. Return
AUM
$2.79B
AUM Growth
-$323M
Cap. Flow
-$496M
Cap. Flow %
-17.8%
Top 10 Hldgs %
54.72%
Holding
493
New
23
Increased
52
Reduced
324
Closed
50
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQE icon
476
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.38B
-2,382
Closed -$211K
RSPG icon
477
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$546M
-4,021
Closed -$324K
SCHH icon
478
Schwab US REIT ETF
SCHH
$11.4B
-11,970
Closed -$239K
SGOV icon
479
iShares 0-3 Month Treasury Bond ETF
SGOV
$100B
-2,096
Closed -$211K
SHEL icon
480
Shell
SHEL
$245B
-3,208
Closed -$232K
SMH icon
481
VanEck Semiconductor ETF
SMH
$73.2B
-1,702
Closed -$444K
SPMD icon
482
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.9B
-13,798
Closed -$708K
SPRY icon
483
ARS Pharmaceuticals
SPRY
$612M
-32,174
Closed -$274K
VAW icon
484
Vanguard Materials ETF
VAW
$3.13B
-1,546
Closed -$298K
VDC icon
485
Vanguard Consumer Staples ETF
VDC
$7.99B
-2,045
Closed -$415K
VIS icon
486
Vanguard Industrials ETF
VIS
$8.39B
-2,172
Closed -$511K
VT icon
487
Vanguard Total World Stock ETF
VT
$79.8B
-5,400
Closed -$608K
WBD icon
488
Warner Bros
WBD
$67.1B
-10,462
Closed -$77.8K
XJR icon
489
iShares ESG Screened S&P Small-Cap ETF
XJR
$190M
-17,535
Closed -$664K
ZTS icon
490
Zoetis
ZTS
$30B
-1,569
Closed -$272K
SOLV icon
491
Solventum
SOLV
$14.1B
-5,558
Closed -$294K
GRTS
492
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
-17,858
Closed -$11K
ASXC
493
DELISTED
Asensus Surgical, Inc.
ASXC
-12,936
Closed -$4.31K

Similar funds

Avantax Planning Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Avantax Planning Partners held 493 positions worth $2.79B, down 10% from $3.11B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Avantax Planning Partners withdrew a net $496M in Q3 2024, closing 50 positions and reducing 324 holdings. Its most notable exit was iShares iBonds Dec 2028 Term Corporate ETF, an estimated $2.14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 4.7% of assets, down from 5% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Avantax Planning Partners opened a new position in Vertex Pharmaceuticals worth $397K.

  • Avantax Planning Partners's largest Q3 2024 buy was Vertex Pharmaceuticals: 854 shares worth $397K.
  • Avantax Planning Partners added most to JPMorgan International Bond Opportunities ETF in Q3 2024, an estimated $8.66M increase.
  • Avantax Planning Partners's biggest Q3 2024 reduction was Schwab US Large-Cap Growth ETF, cutting an estimated $59.3M.
  • Avantax Planning Partners fully exited iShares iBonds Dec 2028 Term Corporate ETF in Q3 2024, selling an estimated $2.14M.
  • Avantax Planning Partners's ten largest holdings make up 55% of its $2.79B portfolio in Q3 2024.
  • Avantax Planning Partners opened 23 new positions and closed 50 in Q3 2024.
  • Avantax Planning Partners's portfolio value fell 10% quarter-over-quarter to $2.79B.

Based on Avantax Planning Partners's 13F filing for Q3 2024, filed 14 Nov 2024.